Close
You must relate an iCM form to this article

Skip Navigation
Search site
Search Help

Hospital Prescribing - England, 2010

Publication date: October 18, 2011
Return to Find data

Resources

Summary

This report compares expenditure between primary and secondary care in total and for selected areas, including medicines positively appraised by NICE. Specific areas covered this year are ADHD, psychosis and anti-TNF medicines.

Key facts

  • Total prescribing costs in 2010 were £12.9 billion
  • In 2010 hospital use accounted for 31.7 per cent of the total cost, up from 30.9 per cent in 2009.
  • The cost of medicines rose by 4.8 per cent overall but by 7.7 per cent in hospitals
  • Of the drugs positively appraised by NICE, the greatest overall cost was for atorvastatin but adalimumab incurred the greatest cost in hospitals.
  • The route by which patients receive drugs for Attention Deficit Hyperactivity Disorder varies widely between Strategic Health Authorities. In 2010 the proportion of drugs for ADHD (measured in Defined Daily Doses) prescribed in hospitals but dispensed in the community ranged from 10.4 per cent to 32.1 per cent.

Coverage

Date Range: January 01, 2010 to December 31, 2010
Geographical coverage:
England
Geographical granularity:
Strategic Health Authorities
Country

Related links

View previous versions of this publication
Return to Find data